Aromatase cytochrome P450 gene expression in endometrial carcinoma
1996

Aromatase Gene Expression in Endometrial Carcinoma

Sample size: 7 publication Evidence: low

Author Information

Author(s): H Sasanol, K Kaga, S Sato, A Yajima, H Nagura, N Harada

Primary Institution: Tohoku School of Medicine, Sendai, Japan; Fujita-Gakuen Health University, Toyoaeke, Japan

Hypothesis

Does alternative splicing of the aromatase gene contribute to its overexpression in endometrial carcinoma?

Conclusion

The study found varying levels of aromatase expression in endometrial carcinoma, suggesting that alternative splicing may play a role in its regulation.

Supporting Evidence

  • Strong aromatase immunoreactivity was found in stromal cells of carcinoma in five out of seven cases.
  • Varying levels of aromatase transcripts were detected in five cases.
  • Alternative splicing of the aromatase gene may contribute to its overexpression in endometrial carcinoma.

Takeaway

This study looked at how a gene that helps make estrogen behaves in certain types of cancer in the uterus, finding that it can act differently in different cases.

Methodology

The study used immunohistochemistry and RT-PCR to analyze aromatase gene expression in seven endometrial carcinoma specimens.

Limitations

The small sample size limits the generalizability of the findings.

Participant Demographics

The study included seven patients with endometrioid endometrial carcinoma, with ages ranging from 30 to 69 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication